Stifel Financial Corp lifted its holdings in MetLife, Inc. (NYSE:MET) by 0.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 969,300 shares of the financial services provider’s stock after purchasing an additional 1,875 shares during the period. Stifel Financial Corp owned 0.09% of MetLife worth $50,334,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Prudential Financial Inc. increased its stake in shares of MetLife by 71.4% in the second quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock worth $201,778,000 after purchasing an additional 1,529,570 shares during the period. Schwab Charles Investment Management Inc. increased its stake in shares of MetLife by 5.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,555,656 shares of the financial services provider’s stock worth $195,348,000 after purchasing an additional 175,311 shares during the period. PGGM Investments increased its stake in shares of MetLife by 2.3% in the third quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock worth $29,972,000 after purchasing an additional 12,978 shares during the period. KBC Group NV increased its stake in shares of MetLife by 14.3% in the second quarter. KBC Group NV now owns 1,263,802 shares of the financial services provider’s stock worth $69,433,000 after purchasing an additional 157,734 shares during the period. Finally, Rockefeller Financial Services Inc. increased its stake in shares of MetLife by 189.7% in the third quarter. Rockefeller Financial Services Inc. now owns 37,153 shares of the financial services provider’s stock worth $1,930,000 after purchasing an additional 24,330 shares during the period. Institutional investors and hedge funds own 76.37% of the company’s stock.
In other news, insider Christopher G. Townsend sold 82,731 shares of MetLife stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the completion of the transaction, the insider now owns 49,660 shares in the company, valued at $2,711,436. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christopher G. Townsend sold 55,712 shares of MetLife stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the transaction, the insider now owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.
MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.19. The company had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The company’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.28 earnings per share. equities analysts expect that MetLife, Inc. will post 4.43 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 13th. Shareholders of record on Monday, November 6th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.98%. The ex-dividend date of this dividend is Friday, November 3rd. MetLife’s payout ratio is -320.00%.
MET has been the topic of a number of recent research reports. Royal Bank Of Canada reissued a “buy” rating and set a $56.00 target price on shares of MetLife in a research report on Wednesday, September 6th. UBS reissued a “neutral” rating and set a $49.00 target price (down from $57.00) on shares of MetLife in a research report on Friday, September 1st. ValuEngine downgraded MetLife from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 26th. Zacks Investment Research raised MetLife from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a research report on Thursday, November 9th. Finally, Sandler O’Neill downgraded MetLife from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $58.40.
ILLEGAL ACTIVITY WARNING: “Stifel Financial Corp Buys 1,875 Shares of MetLife, Inc. (MET)” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.com-unik.info/2017/12/04/stifel-financial-corp-buys-1875-shares-of-metlife-inc-met.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).
What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.